Microglia present in the tumour microenvironment can suppress the immune response from the production of arginase 1 (Arg1) and pro-inflammatory and proliferative microglia have the potential to drive the progression of GBM [35,36]. This evidence concerns the gene ARG1 and glioblastoma.